DHA, EPA, and Ocular Health

2012 ◽  
pp. 89-101
Author(s):  
Jeffrey Anshel
Keyword(s):  
Author(s):  
Tanisha Martheswaran ◽  
Margaret H. Shmunes ◽  
Yasmyne C. Ronquillo ◽  
Majid Moshirfar

Nutrients ◽  
2019 ◽  
Vol 11 (9) ◽  
pp. 2123 ◽  
Author(s):  
John G. Lawrenson ◽  
Laura E. Downie

Diet is a key lifestyle factor that can have long-term effects on ocular health [...]


2020 ◽  
Vol 2020 ◽  
pp. 1-15 ◽  
Author(s):  
Holly R. Chinnery ◽  
Kate E. Keller

Cellular communication is an essential process for the development and maintenance of all tissues including the eye. Recently, a new method of cellular communication has been described, which relies on formation of tubules, called tunneling nanotubes (TNTs). These structures connect the cytoplasm of adjacent cells and allow the direct transport of cellular cargo between cells without the need for secretion into the extracellular milieu. TNTs may be an important mechanism for signaling between cells that reside long distances from each other or for cells in aqueous environments, where diffusion-based signaling is challenging. Given the wide range of cargoes transported, such as lysosomes, endosomes, mitochondria, viruses, and miRNAs, TNTs may play a role in normal homeostatic processes in the eye as well as function in ocular disease. This review will describe TNT cellular communication in ocular cell cultures and the mammalian eye in vivo, the role of TNTs in mitochondrial transport with an emphasis on mitochondrial eye diseases, and molecules involved in TNT biogenesis and their function in eyes, and finally, we will describe TNT formation in inflammation, cancer, and stem cells, focusing on pathological processes of particular interest to vision scientists.


2010 ◽  
Vol 5 (4) ◽  
pp. 557-577 ◽  
Author(s):  
Kathryn Skarbez ◽  
Yos Priestley ◽  
Marcia Hoepf ◽  
Steven B Koevary

Eye ◽  
2017 ◽  
Vol 32 (1) ◽  
pp. 50-52 ◽  
Author(s):  
R I Chee ◽  
R V P Chan

2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Clement Chinedu Azodo ◽  
Ejike B Ezeja

2020 ◽  
Vol 21 (23) ◽  
pp. 9267
Author(s):  
Massimo Dal Monte ◽  
Maurizio Cammalleri ◽  
Rosario Amato ◽  
Salvatore Pezzino ◽  
Roberta Corsaro ◽  
...  

Melatonin is of great importance for regulating several eye processes, including pressure homeostasis. Melatonin in combination with agomelatine has been recently reported to reduce intraocular pressure (IOP) with higher efficacy than each compound alone. Here, we used the methylcellulose (MCE) rat model of hypertensive glaucoma, an optic neuropathy characterized by the apoptotic death of retinal ganglion cells (RGCs), to evaluate the hypotensive and neuroprotective efficacy of an eye drop nanomicellar formulation containing melatonin/agomelatine. Eye tissue distribution of melatonin/agomelatine in healthy rats was evaluated by HPLC/MS/MS. In the MCE model, we assessed by tonometry the hypotensive efficacy of melatonin/agomelatine. Neuroprotection was revealed by electroretinography; by levels of inflammatory and apoptotic markers; and by RGC density. The effects of melatonin/agomelatine were compared with those of timolol (a beta blocker with prevalent hypotensive activity) or brimonidine (an alpha 2 adrenergic agonist with potential neuroprotective efficacy), two drugs commonly used to treat glaucoma. Both melatonin and agomelatine penetrate the posterior segment of the eye. In the MCE model, IOP elevation was drastically reduced by melatonin/agomelatine with higher efficacy than that of timolol or brimonidine. Concomitantly, gliosis-related inflammation and the Bax-associated apoptosis were partially prevented, thus leading to RGC survival and recovered retinal dysfunction. We suggest that topical melatoninergic compounds might be beneficial for ocular health.


2014 ◽  
Vol 19 (4) ◽  
pp. 493-498
Author(s):  
Hyojin Kim ◽  
Hyi Jin Kim ◽  
Chang Won Park ◽  
Eun-Hee Lee ◽  
Hee Ju Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document